Targeting CD44 and other pleiotropic co-receptors as a means for broad inhibition of tumor growth and metastasis. - Mehner LM; Munoz-Sagredo L; Sonnentag SJ; Treffert SM; Orian-Rousseau V (Clinical & experimental metastasis, 2024)